Widerøe T E, Dahl K J
Medisinsk avdeling, Regionsykehuset i Trondheim.
Tidsskr Nor Laegeforen. 1998 Jun 10;118(15):2335-8.
The Norwegian Report on Evaluation and Treatment of Mild Hypertension and The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure were both published at the end of 1997. The prevalence of hypertension and the proportion of the total adult population on antihypertensive medication is about 20% and 10% respectively in both countries. In both reports patients are assessed and graded according to various risk factors for developing cardiovascular disease. However, in the American recommendations it seems that this will only have marginal impact on the number of persons with uncomplicated mild hypertension who will be recommended drug therapy. The Norwegian guidelines recommend drug therapy only where there is a minimum of 20% absolute risk (30% for the age group 60-69 years) of developing cardiovascular disease or of death within ten years. Drug therapy is not recommended for persons over 70 years with uncomplicated mild hypertension, whereas treatment is advised in cases of complicated mild hypertension. It is therefore estimated that drug therapy will be recommended for less than 50% of patients with uncomplicated mild hypertension, as opposed to almost 100% according to the American guidelines.
《挪威轻度高血压评估与治疗报告》以及《美国国家联合委员会关于高血压预防、检测、评估与治疗的第六次报告》均于1997年末发布。两国高血压的患病率以及服用降压药物的成年人口比例分别约为20%和10%。两份报告均根据患心血管疾病的各种风险因素对患者进行评估和分级。然而,在美国的建议中,这似乎对将被推荐药物治疗的单纯性轻度高血压患者数量的影响微乎其微。挪威的指导方针建议,只有在未来十年内发生心血管疾病或死亡的绝对风险至少为20%(60 - 69岁年龄组为30%)时才进行药物治疗。对于70岁以上患有单纯性轻度高血压的患者不建议进行药物治疗,而对于复杂性轻度高血压患者则建议进行治疗。因此,据估计,对于单纯性轻度高血压患者,推荐药物治疗的比例将不到50%,而根据美国的指导方针这一比例几乎为100%。